Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Comma Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹183.31 |
| 26 Aug 2009 | ₹109.48 |
| 08 May 2011 | ₹111.74 |
| 17 Jan 2013 | ₹98.21 |
| 30 Sep 2014 | ₹113.34 |
| 11 Jun 2016 | ₹118.52 |
| 21 Feb 2018 | ₹187.18 |
| 04 Nov 2019 | ₹148.63 |
| 16 Jul 2021 | ₹261.68 |
| 28 Mar 2023 | ₹240.05 |
| 08 Dec 2024 | ₹407.89 |
| 20 Aug 2026 | ₹458.04 |
| Metric | SBI · Regular · IDCW NAV ₹66.69 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| +11.99% | +3.54% | |
| +17.49% | +11.47% | |
| +12.03% | +9.70% | |
| +12.94% | +10.32% | |
| +7.75% | +9.15% | |
| +13.85% | — | |
| +8.53% | +12.10% | |
| +8.05% | +10.32% | |
| +8.15% | +8.80% | |
| Risk | ||
| 18.07% | 15.91% | |
| 0.61 | 0.25 | |
| 0.80 | 0.32 | |
| -68.97% | -26.14% | |
| Nifty 500 | — | |
| +4.68% | -0.04% | |
| 0.99 | 0.98 | |
| 108.1% | 98.3% | |
| 84.2% | 101.5% | |
| 2.30% | 2.38% | |
| ₹931.17Cr | ₹1,160Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 52% | 42% | |
| Pradeep Kesavan · 2.7y | — | |
| 03 Apr 2006 | — | |
| 41 | — | |
| 42.7% | — | |
| 5.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.